# Novavax Inc: Form SCHEDULE 13D/A, filed Nov 12, 2025

- Company: [Novavax Inc](/companies/nvax.md) (CIK 1000694)
- Form: SCHEDULE 13D/A
- Filed: 2025-11-12
- Accepted by EDGAR: Nov 12, 2025, 16:17 ET
- Period: not reported
- Accession: 0001398344-25-020786
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1000694/000139834425020786/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1000694/000139834425020786/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1000694/000139834425020786/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Nov 12, 2025.
Source: SEC EDGAR, the filing index for accession 0001398344-25-020786. Last ingested by Listed: Nov 5, 2026, 12:23 ET. No prices; not investment advice.